Abstract:Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple systems of the body. Recent research on the gut microbiota dysbiosis associated with SLE patients has gained traction and warranted further exploration. It has not been determined whether the change in the gut microbiota is a cause of SLE or a symptom of SLE. However, based on the physiological and pathophysiological role of the bacteria in the gut microbiome, as levels of the bacteria rise or fall, symptomatology in SLE patients could be affected. This review analyzes the recent studies that examined the changes in the gut microbiota of SLE patients and highlights the correlations between gut dysbiosis and the clinical manifestations of SLE. A systematic search strategy was developed by combining the terms "SLE," "systemic lupus erythematosus," and "gut microbiome." Biomedical Reference Collection, CINAHL, Medline ProQuest, and PubMed Central databases were searched by combining the appropriate keywords with "AND." Only full-text, English-language articles were searched. The articles were restricted from 2013 to 2023. Only peer-reviewed controlled studies with both human and animal trials were included in this scoping review. Review articles, non-English articles, editorials, case studies, and duplicate articles from the four databases were excluded. Various species of bacteria were found to be positively or negatively associated with SLE gut microbiomes. Among the bacterial species increased were Clostridium, Lactobacilli, Streptococcus, Enterobacter, and Klebsiella. The bacterial species that decreased were Bifidobacteria, Prevotella, and the Firmicutes/Bacteroidetes ratio. Literature shows that Clostridium is one of several bacteria found in abundance, from pre-disease to the diseased state of SLE. Lachnospiraceae and Ruminococcaceae are both part of the family of butyrate-producing anaerobes that are known for their role in strengthening the skin barrier function and, therefore, may explain the cutaneous manifestations of SLE patients. Studies have also shown that the Firmicutes/Bacteroidetes ratio is significantly depressed, which may lead to appetite changes and weight loss seen in SLE patients. Based on the established role of these bacteria within the gut microbiome, the disruption in the gut ecosystem could explain the symptomatology common in SLE patients. By addressing these changes, our scoping review encourages further research to establish a true causal relationship between the bacterial changes in SLE patients as well as furthering the scope of microbiota changes in other systems and autoimmune diseases.

The gut microbiota of non-treated patients with SLE defines an autoimmunogenic and proinflammatory profile.

An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus

Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus.

Gut Microbiota in Systemic Lupus Erythematosus: A Fuse and a Solution

Lupus Gut Microbiota Transplants Cause Autoimmunity and Inflammation

Compositional and functional aberrance of the gut microbiota in treatment-naïve patients with primary Sjögren's syndrome

Gut microbiota regulation of T lymphocyte subsets during systemic lupus erythematosus

Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery

Gut microbiota in systemic lupus erythematosus pathogenesis: an in-depth view of mechanisms inside

Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention

Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives

Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders

A Scoping Review of the Positive and Negative Bacteria Associated With the Gut Microbiomes of Systemic Lupus Erythematosus Patients

Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus

Gut Microbiota in Systemic Lupus Erythematosus and Correlation With Diet and Clinical Manifestations

The Microbiota in Systemic Lupus Erythematosus: An Update on the Potential Function of Probiotics

The Influence and Therapeutic Effect of Microbiota in Systemic Lupus Erythematosus

Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies

Let’s review the gut microbiota in systemic lupus erythematosus

Alterations of the fecal and vaginal microbiomes in patients with systemic lupus erythematosus and their associations with immunological profiles

Fungal gut microbiota dysbiosis in systemic lupus erythematosus